Improved survival in HIV associated Kaposi sarcoma (KS) treated with chemotherapy and protease inhibitor (PI) based antiretroviral therapy.

被引：0
|
作者：
Leitch, HA
Routy, JP
机构：
[1] McGill Univ, Ctr Hlth, Div Hematol, Montreal, PQ, Canada
[2] McGill Univ, Ctr Hlth, Immunodeficiency Serv, Montreal, PQ, Canada
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3363
引用
收藏
页码：48B / 48B
页数：1
相关论文
共 50 条
  • [1] Effect of protease inhibitor-based highly active antiretroviral therapy on survival in HIV-associated advanced Kaposi's sarcoma patients treated with chemotherapy
    Leitch, H
    Trudeau, M
    Routy, JP
    [J]. HIV CLINICAL TRIALS, 2003, 4 (02): : 107 - 114
  • [2] Effect of highly active antiretroviral therapy on survival in patients with AIDS-associated pulmonary Kaposi's sarcoma treated with chemotherapy
    Holkova, B
    Takeshita, K
    Cheng, DM
    Volm, M
    Wasserheit, C
    Demopoulos, R
    Chanan-Khan, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (18) : 3848 - 3851
  • [3] HIV-Associated Kaposi Sarcoma in the Combination Antiretroviral Therapy Era
    Mangusan, Ralph E.
    Ekwede, Irene
    Widell, Anaida
    [J]. AMERICAN JOURNAL OF NURSING, 2022, 122 (12) : 32 - 40
  • [4] Immunosenescence is associated with presence of Kaposi's sarcoma in antiretroviral treated HIV infection
    Unemori, Patrick
    Leslie, Kieron S.
    Hunt, Peter W.
    Sinclair, Elizabeth
    Epling, Lorrie
    Mitsuyasu, Ronald
    Effros, Rita B.
    Dock, Jeffrey
    Dollard, Sheila G.
    Deeks, Steven G.
    Martin, Jeffrey N.
    Maurer, Toby A.
    [J]. AIDS, 2013, 27 (11) : 1735 - 1742
  • [5] Health-Related Quality of Life in Patients Treated With Antiretroviral Therapy Only Versus Chemotherapy and Antiretroviral Therapy for HIV-Associated Kaposi Sarcoma: A Randomized Control Trial
    Shaik, Fahmida
    Uldrick, Thomas S.
    Esterhuizen, Tonya
    Mosam, Anisa
    [J]. JOURNAL OF GLOBAL ONCOLOGY, 2018, 4 : 1 - 9
  • [6] Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy
    V Martinez
    E Caumes
    L Gambotti
    H Ittah
    J-P Morini
    J Deleuze
    I Gorin
    C Katlama
    F Bricaire
    N Dupin
    [J]. British Journal of Cancer, 2006, 94 : 1000 - 1006
  • [7] Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy
    Martinez, V
    Caumes, E
    Gambotti, L
    Ittah, H
    Morini, JP
    Deleuze, J
    Gorin, I
    Katlama, C
    Bricaire, F
    Dupin, N
    [J]. BRITISH JOURNAL OF CANCER, 2006, 94 (07) : 1000 - 1006
  • [8] No increased risk of Kaposi sarcoma relapse in patients with controlled HIV-1 infection after switching protease inhibitor-based antiretroviral therapy
    Lajaunie, Rebecca
    Cuzin, Lise
    Palich, Romain
    Makinson, Alain
    Bani-Sadr, Firouze
    Duvivier, Claudine
    Arvieux, Cedric
    Rey, David
    Poizot-Martin, Isabelle
    Delpierre, Cyril
    Delobel, Pierre
    Martin-Blondel, Guillaume
    [J]. HIV MEDICINE, 2022, 23 (03) : 301 - 306
  • [9] Timing of highly active antiretroviral therapy and chemotherapy for Kaposi's sarcoma in patients with HIV infection
    Loke, W. C.
    Spittle, M. F.
    Mitchell, S.
    Kulasegaram, R.
    [J]. INTERNATIONAL JOURNAL OF STD & AIDS, 2006, 17 (08) : 565 - 566
  • [10] Excellent clinical outcomes and retention in care for adults with HIV-associated Kaposi sarcoma treated with systemic chemotherapy and integrated antiretroviral therapy in rural Malawi
    Herce, Michael E.
    Kalanga, Noel
    Wroe, Emily B.
    Keck, James W.
    Chingoli, Felix
    Tengatenga, Listern
    Gopal, Satish
    Phiri, Atupere
    Mailosi, Bright
    Bazile, Junior
    Beste, Jason A.
    Elmore, Shekinah N.
    Crocker, Jonathan T.
    Rigodon, Jonas
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2015, 18
12345